About NanGenex Inc.

NanGenex is member of the DRGT Group. Headquartered in Malta, Druggability Technologies (DRGT) is a specialty pharmaceutical company dedicated to the development and commercialization of high-value proprietary drugs that deliver measurable and meaningful improvement in clinical utility. Utilizing the Super-API platform the Company carefully selects and screens drugs and develops their Super-API compositions. 

One of its subsidiaries, NanGenex Inc., is the technology company that develops and advances to the clinic specific high value compounds selected by DRGT. NanGenex is based in Budapest and was established in 2006 to develop the continuous flow based Super-API technology and the related full scale, intelligent and integrated, GMP compliant instrument line.